|
⚲
|
| Keyboard |
| Mark Hooper | |
|---|---|
| Firm | |
| Address | 524 S Main St Suite 110 Ann Arbor, MI 48104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ONL Therapeutics Inc | 021-507285 | Director | 10.0 M of 10.0 M |
||
| ONL Therapeutics Inc | 021-475907 | Director | 5.0 M of 15.0 M |
||
| ONL Therapeutics Inc | 021-384866 | Director | 26.8 M of 47.4 M |
||
| ONL Therapeutics Inc | 021-379321 | Director | 2.0 M of 2.0 M |
||
| ONL Therapeutics Inc | 021-347166 | Director | 3.0 M of 3.0 M |
||
| ONL Therapeutics Inc | 021-321881 | Director | 0.6 M of 1.0 M |
||
| ONL Therapeutics Inc | 021-287138 | Director | 2.6 M of 4.3 M |
||
| ONL Therapeutics Inc | 021-268602 | Director | 0.9 M of 1.2 M |
||
| ONL Therapeutics Inc | 021-220089 | Director | 0.5 M of 1.0 M |
||